Two series of fibers containing the active ingredients acyclovir, ciprofloxacin and 24 cyanocobalamin, and combinations of these drugs, were prepared by electrospinning. One set 25 used the hydrophilic poly(vinylpyrrolidone) (PVP) as the filament-forming polymer, while the 26 other used the slow-dissolving poly(ε-caprolactone) (PCL). The fibers were found to have 27 cylindrical morphologies, although there was evidence for solvent occlusion with the PVP 28 systems and for some drug particles in the PCL case. The active ingredients were generally 29 present in the amorphous physical form in the case of PVP, but evidence of crystallinity was 30 observed with PCL. The existence of intermolecular interactions between the drugs and 31 polymers was proven using simple molecular modeling calculations. Drug release from the 32 various fibers was tested in a validated in vitro outflow model of the eye, and the fiber 33 formulations found to be capable of extending drug release. We thus conclude that electrospun 34 matrices such as those prepared in this work have potential for use as intravitreal implants. 35 36 Keywords 37 Electrospinning, ocular drug delivery, in vitro, half-life, antivirals, posterior segment, fibers, 38 sustained release. 39 40 Chemical compounds used in this work 41 Acyclovir (Pubchem ID: 2022); ciprofloxacin (2764); cyanocobalamin (5311498).
Introduction

44
Cytomegalovirus (CMV) infections are a major clinical problem in patients with AIDS. Their main 45 manifestation in AIDS patients is retinitis, which accounts for 20-30% of all cases (Pollard, 46 1996). Common symptoms of CMV retinitis include visual field defects with decreased acuity, the presence of floaters, and photophobia. Complications arise when retinitis is localized near eye since it is challenging to prepare a solution with sufficient solubility to exert a therapeutic 69 effect. Ciprofloxacin (CIP) is widely used to prevent and cure bacterial infections, and thus can 70 be used with ACY to provide broad-spectrum anti-pathogenic activity. It too has very poor 71 water solubility. Cyanocobalamin (vitamin B12) has been reported to repair damage to the eye, 72 and is used as a reparative agent in some eye drops (e.g. Sante Beautéye (Santen 73 Pharmaceutical Co, 2013)). A formulation containing all three ingredients, with solubility 74 enhancement for ACY and CIP, would thus be a useful addition to the gamut of treatments for 75 viral diseases of the eye. 76 
77
Various strategies can be applied to increase the solubility and dissolution rate of poorly soluble 78 drugs; one popular approach is to prepare amorphous dispersions of the active pharmaceutical 79 ingredient (API) in a polymer matrix. The formation of such a solid solution or solid suspension 80 removes the lattice energy barrier to dissolution, and the polymer carrier additionally helps to 81 stabilize the amorphous form by preventing the API molecules from crystallizing. One method 82 which has been widely explored to generate such pharmaceutical composites is electrospinning 83 (Chakraborty et al., 2009; Williams et al., 2012) . This approach is attractive in its simplicity. A 84 co-dissolving solution of a polymer and an API is first prepared in a volatile solvent. This is then 85 loaded into a syringe fitted with a metal needle (the spinneret). The polymer solution is ejected 86 from the syringe towards a metal collector plate at a constant rate, controlled using a syringe 87 pump. A high potential difference is applied between the spinneret (positive) and collector Waltham, MA, USA) over the range 650 -4000 cm -1 and at a resolution of 1 cm -1 . A range of optimization experiments were initially undertaken in which the processing 250 parameters (voltage, polymer concentration, solvent system) were systematically varied. As a 251 result, the conditions listed in Section 2.2 were adopted for further studies. These permitted 252 fibers to be prepared with PVP and all three active ingredients. SEM images of the PVP systems 253 are given in Figure 3 , and details of the fiber sizes in Table 5 . alternatives was explored, and 1:1 v/v chloroform/methanol was found to be suitable for PCL. 277 The fibers produced are depicted in Figure 4 , and their diameters summarized in Table 5 . 341 The interactions between the drug and polymer were investigated using both IR spectroscopy 342 and molecular modelling. This is not surprising given that the diagnostic vibration bands for the APIs occur over the same 353 wavenumber range as those of the polymers (see Figure 7 (a)), and also in many cases the drug 354 loading is low (< 5 % w/w). As a result, it is not possible to say from these data whether there 355 are any interactions between the APIs and polymers, although from their chemical structures it 356 is thought that such interactions are likely to arise. To probe these possibilities in more detail, 357 simple molecular models were constructed. Figure 8 . 368 The energetic contributions to the overall steric energy for both the drug-polymer complexes 369 and the individual API and PVP or PCL decamers are presented in Table 6 . Stabilization of the 389 This assumption has been validated in a previous study (Awwad et al., 2015) . The release data 390 from the single drug-loaded fibers are given in Figure 9 , and a summary of the calculated 391 parameters for all the fibers can be found in Table 7 . When the ACY loaded PVP fibers were tested in the PK-Eye, the drug concentration displayed a 408 mono-exponential decrease following first order kinetics (Figure 9(a) ). The fibers led to an ACY The PCL-ABC fibers were also tested in the PK-Eye ( Figure 10 ). The highest concentrations of 460 ACY, B12 and CIP detected in the model were around 39.7 ± 2.4 μg/mL (17 hours), 14.3 ± 1.9 461 μg/mL (17 hours) and 3.6 ± 0.12 μg/mL (208 hours) respectively. With these fibers, both ACY 462 and B12 release followed first order kinetics while CIP followed zero order kinetics. The 463 residence times for ACY, B12 and CIP were 1.4 ± 0.08 days, 6.16 ± 0.6 days and 2.99 ± 0.19 days. 
Drug-polymer interactions
Conclusions
482
Two series of electrospun fibers were successfully prepared for ocular drug delivery suggesting that the strategy adopted in this work is a viable one for the generation of 494 intravitreal implants. 495
5.
Solubility of antibiotics in different solvents. 
